Top 50 Medical Startup Investors in Italy in May 2026
Top 50 Medical Startup Investors in Italy in May 2026
Reach every investor
Get a list of investors who already back your industry, stage, and country. Emails & phones included.
Find investors — It's Free!CDP Venture Capital Sgr - National Innovation Fund aims to make venture capital a cornerstone of the country's economic development and innovation, creating the conditions for an overall and sustainable growth of the venture capital ecosystem.
Show more...Investment focus
- Software, Information Technology, Health Care
- Seed, Series A, Funding Round
- Italy, United States, United Kingdom
Portfolio highlights
- ALBA Robot — Through our micro mobility platform we add autonomy and artificial intelligence to transform passengers transportation.
- RARA Factory — RARA Factory is a company that provides research and development of sustainable materials utilizing physics-based artificial intelligence.
- Proxima Fusion — We are a European fusion energy startup pursuing the clearest path to grid deployment.
IAG is an angel investor network that offers access to its affiliates to early-stage venture opportunities. Its members to date have deployed over 22 million Euros to support 41 startups in the series seed/series A stage in many verticals, among which: Medtech, SAAS, e-commerce, Fintech, and high tech at large. Every investment opportunityat IAG is vetted by a professional team together with expert members of the group. Once invested, the company receives the support of up to two Investment champions, who bring their expertise to the table and help them succeed.
Show more...Investment focus
- Software, E-Commerce, Health Care
- Seed, Angel, Series A
- Italy, United States, United Kingdom
Portfolio highlights
- ALKemist Bio — ALKemist Bio is a biotech startup developing next-generation T cell therapies that target ALK-positive cancers. By reprogramming the immune system, the company aims to overcome resistance and deliver more effective, lasting treatments for solid tumors.
- Rubedo Life Sciences — Rubedo Life Sciences is the Premier Longevity Company. Rubedo discovers and develops medicines to keep you biologically young.
- Restorative Neurotechnologies — Siamo un'azienda di dispositivi medicali certificati per la riabilitazione cognitiva ed il trattamento di disturbi cognitivi post ictus.
We are investors in companies that make the difference. We partner with hard-working entrepreneurial visionaries
Show more...Investment focus
- Health Care, Medical, Medical Device
- Funding Round, Series A, Series B
- Italy, United States, Spain
Portfolio highlights
- GreenBone Ortho — GreenBone Ortho was founded in Faenzato offer advanced and innovative solutions in the field of orthopaedics and bone regeneration, using the Rattan wood.
- Renovacor — Renovacor is a preclinical‑stage biopharmaceutical company focused on developing transformative gene therapy‑based treatments for cardiovascular disease.Renovacor’s lead program is a recombinant adeno-associated virus (AAV)‑based gene therapy for patients suffering from dilated cardiomyopathy (DCM) due to mutations in the Bcl2‑associatedathanogene 3 (BAG3) gene.Dilated cardiomyopathy is a condition affecting over 3 million patients in the US and growing steadily. Many patients develop DCM due to ischemic heart disease. Recently subpopulations have been identified that develop DCM due to mutations in specific genes that have been shown to result in the development of DCM. One of these specific genes is the BAG3 gene. The prevalence of disease‑causing BAG3 haploinsufficiency is estimated at approximately 35,000 individuals in the United States, representing an orphan disease by FDA guidelines. It is estimated a similar number of DCM patients with BAG3 mutations exist in Europe. These patients are typically younger and progress to end-stage heart failure sooner than patients with ischemic heart disease. Currently, DCM patients with a BAG3 mutation are treated with standard of care for heart failure. Despite improvements in pharmacotherapy and care, the five‑year survival of a patient with DCM is only 50%. The development of a BAG3 gene replacement therapy for patients with DCM that carry BAG3 mutations could potentially prevent the progression of disease in this otherwise healthy population of young adults.
- BetaGlue Technologies — BetaGlue Therapeutics develops innovative targeted cancer therapy solutions using its proprietary YntraDose technology for nuclear medicine.
Panakès Partners is a Venture Capital firm, based in Milan, which invests in the most ambitious companies and teams, developing revolutionary technologies and products, in the field of life sciences, aiming to improve the lives of people around the world. Panakès, founded in 2015 by Fabrizio Landi, Alessio Beverina and Diana Saraceni, has 250million under management.
Show more...Investment focus
- Health Care, Medical, Medical Device
- Series B, Series A, Series C
- Italy, Switzerland, United Kingdom
Portfolio highlights
- DeepUll — DeepUll is a biotech company that focuses its activity on the development of a new diagnostic system for early-stage sepsis condition. DeepUll’s proposal is based on quickly identifying the pathogens and offering the antibiogram within a few hours on the one hand, and on using the data and learning about the patient’s immunological and functionalstatus on the other. The system allows doctors to predict the future appearance and evolution of sepsis within a short period of time and thus provide a suitable clinical response even before the symptoms arise.
- Salvia BioElectronics — Our mission is to give people with migraine a better life. As a pioneer in the field of medical devices, Salvia BioElectronics is passionately committed to empowering people with migraine to reclaim their lives.
- Endovascular Engineering — Endovascular Engineering is a preclinical stage company developing novel mechanical thrombectomy solutions to address peripheral indications.
A not-only-profit operating investment company, eager to create a bridge between innovative ideas, territory and capital.
Show more...Investment focus
- Software, Biotechnology, Information Technology
- Seed, Series A, Funding Round
- Italy, United Kingdom, France
Portfolio highlights
- QSensAto — QSensAto is a quantum sensing company specializing in the development and research of integrated vapor cells and quantum atomic sensors.
- Agate Sensors — Agate Sensors offers equipment manufacturers advanced sensors that detect, identify, and classify people, vital signs, objects, and more. Their sensors come in a range of sizes, from single pixel devices to full matrix devices, and are produced using standard CMOS production processes, making them both cost-effective and efficient.
- Sparrow Quantum — Sparrow Quantum, a global leader in quantum photonic chip technology. Explore innovative solutions driving advancements in quantum computing, communication, and beyond. Stay ahead with cutting-edge technologies shaping the future.
Invitalia Ventures SGR manages the “Italia Venture Fund I”, a 87€/Ml sized co-investment fund that invests in early stage operations in Italy. They co-invest up to a maximum of 70% in round A (€ 0.5ML - € 1.5ML) in high growth sectors. Invitalia Ventures, with its network of co-investors not only provides risk capital, but also know-how and anetwork for business development. Main LPs includes the Ministery of Economic Development, the European Investment Bank, Cisco Group, the Sardinian Banking Foundation and Metec Group.They are looking for visionary entrepreneurs who share their passion for innovation. Growth is their mission!!For more information please contact us at info@invitaliaventures.it or visit our website: www.invitaliaventures.it
Show more...Investment focus
- Software, Medical, Internet
- Series A, Funding Round, Seed
- Italy, United States, United Kingdom
Portfolio highlights
- Ecomate — The ESG Rating platform for every company
- BigProfiles — A deep understanding of customers let a company tailor marketing campaigns and CRM strategies, but companies have only basic data about customers (e.g. gender or age). External data sources like Social Networks, Public Registries and Socio-Demographic data contain rich information about billions of people, like job titles, levels of education,interests and habits.BigProfiles is a Customer Intelligence SAAS that leverages external information about persons to enrich customer profiling: it can profile a company's customers with previously unknown information about them. Thanks to its Identity Resolution algorithm (the result of a PHD), it identifies a person’s information scattered among external sources.Through this technology, BigProfiles provides customer base analytics and behavior predictions: using Artificial Intelligence on enriched profiles allows to predict churn, fraud and willingness to buy.
- Codemotion — Codemotion is the ecosystem devoted to innovation, focused on developers and coding, open to all programming languages and technologies. Pioneering spirits, it scout the future to deliver a first class experience to our people. Codemotion is one of the biggest tech-conferences in Europe, with an international network of 30.000 developers and 350speakers coming from all over the world and from the most important IT realities.Codemotion draw in its main conferences, thousands of attendees eager to discuss about hottest topics: it tailor for them disruptive proposals ranging from mobile to UX, develops, cloud, big data, gamedev, security, methods, languages, web, Internet of things. Codemotion is also a startup, providing a bunch of services and activities, for personal and business customers.
VENTURE We invest across all sectors with specific focus on technology and digital The largest independent more About Us Portfolio [...]
Show more...Investment focus
- Biotechnology, Health Care, Life Science
- Series A, Series B, Funding Round
- Italy, Switzerland, United States
Portfolio highlights
- Easy Rain — Leading a new automotive era: our modular ecosystem of virtual sensors and active hardware makes cars and autonomous platforms truly safe in every condition.
- CamGraPhIC — Our platform supports the ever-increasing data traffic demand with high-performing and low-power consumption electro-optical engines.
- Iama Therapeutics — At IAMA Therapeutics, we are constantly pushing the boundaries of neuroscience drug discovery to develop new medicines and make a difference in the lives of children suffering from brain disorders and their families. Our purpose is to provide a therapeutic solution to children suffering from neurological conditions and provide their families withthe support they need.
Vertis is a dynamic and independent investment management company authorised by Bank of Italy. It manages five closed-end funds for qualified investors by participating in research projects, spin-offs, startups and PMI and deals with the investments of the innovative Made in Italy.
Show more...Investment focus
- Software, Computer, E-Commerce
- Seed, Series A, Funding Round
- Italy, United States, United Kingdom
Portfolio highlights
- Tuidi — Tuidi is a tech startup that develops predictive models of AI, with a particular focus on the food distribution sector. They combine methodical study of data, personalization of business processes and speed of integration for to return an output that is not only accurate but also free from interpretation difficulties so as to increase profits,reduce stock outages and optimize inventories.
- Titan4 — Titan4 provides products and services based on research combining different satellite data and sources for applications. They also provide development and integration, InSAR data analysis and data mining, geological analysis, and deep learning analytic services.
- Live Story Inc. — The no-code frontend creative platform for enterprise digital, e-commerce and marketing teams. Design, publish and personalise digital experiences. Design to market with no developer queue and no compromises on governance.
INGENIUM Emilia Romagna was started with EUR 5.30 million by the Emilia Romagna region and EUR 1.7 million from fund managers. Managed by META Investment, the nine-year fund operated through the temporary acquisition of minority stakes in high-opportunity technological companies. It is now fully invested.
Show more...Investment focus
- Medical, Health Care, Privacy
- Seed, Angel, Funding Round
- Italy
Portfolio highlights
- CellPly — Cellply offers an automated platform for functional precision medicine. We provide single-cell drug response profiling to guide oncology treatments...
- GreenBone Ortho — GreenBone Ortho was founded in Faenzato offer advanced and innovative solutions in the field of orthopaedics and bone regeneration, using the Rattan wood.
- Angiodroid — Angiodroid srl, a medical technology company, focuses on hemodynamics, vascular surgery, and interventional radiology. It offers an automatic injection system for carbon dioxide angiography. Its products include carbon dioxide injector that is used as a contrast medium for pheriperal interventional angiography; and a single use kit, which iscomposed of French catheters and a custom connection line. The company is based in San Lazzaro di Savena, Italy.
Lazio Innova is a venture capital firm with its headquarters in Rome in Italy. The firm provides services in areas such as credit support and guarantees, interventions in risk capital, internationalization services, promotion of business networks and services for the creation and enterprise development.
Show more...Investment focus
- Software, Health Care, Artificial Intelligence
- Seed, Pre-Seed, Grant
- Italy, United Kingdom
Portfolio highlights
- Joinrs — Cut the noise. Joinrs uses AI to find the jobs that actually match your skills, experience and preferences. Over 2 million job seekers trust Joinrs.
- Medicud — Medicud develops a device for treating wounds with negative pressure dressing.
- Ticketoo — Compra e vendi biglietti in modo etico su Ticketoo. La piattaforma sicura per transazioni fan-to-fan. Trova i migliori eventi e assicurati il biglietto per i tuoi spettacoli preferiti.
Lumen Ventures is a venture capital firm that focuses on seed investments, early-stage investments, and private equity.
Show more...Investment focus
- B2B, B2C, Mobile
- Seed, Pre-Seed, Series A
- Italy
Portfolio highlights
- GenomeUp — GenomeUp is an AI platform (SaaS) to enabling doctors and clinical institutions to diagnose and treat rare genetic diseases in less than 24h. GenomeUp is involved in international research projects and clinical trials in partnership with universities and research centers.
- Insoore — Insoore is a platform that helps insurance companies to improve the claims management process, thanks to on-demand photographic inspections and damage estimates provided by a community of experts.
- Carol — Carol is a tech-enabled healthcare provider delivering membership-based primary care services, on a mission to make high-quality healthcare accessible and affordable for everyone. To achieve this goal, Carol leverages a highly scalable technology, combined with high quality clinical operations and a salaried provider model.
Luca Trevisan Sales Manager and Business Coordinator.
Show more...Investment focus
- Medical, Health Care, Medical Device
- Series A
- Italy
Portfolio highlights
- I-VASC — I-VASC has developed the VELEX device using new technology to treat CVI and varicose veins.
Scientifica Venture Capital offers private equity and venture capital investment services for Italy based startups and firms.
Show more...Investment focus
- Biotechnology, Health Care, Manufacturing
- Seed, Pre-Seed, Funding Round
- Italy, Sweden, Finland
Portfolio highlights
- PlantBit — PlantBit is a producer of sensors and services for smart farming.
- LOTO Biotech — LOTO Biotech is a biotechnology platform focused on supporting the development of treatments for rare diseases, particularly those caused by dominant negative genetic mutations.
- LayerLogic AB — Reliable and instantaneous bacteria detection
Helsinn Investment Fund S.A. is a Luxembourg fund focused on early-stage investments in areas of high unmet patient need.
Show more...Investment focus
- Biotechnology, Therapeutics, Medical
- Series B, Series A, Funding Round
- United States, Italy, United Kingdom
Portfolio highlights
- NeoPhore — NeoPhore targets the dynamics of cancer neoantigen evolution and makes effective medicines that will become a key part of the next-generation of cancer immunotherapies.
- Fore Biotherapeutics — We are a precision oncology company pioneering the development of cancer therapies guided by our proprietary functional genomics.
- On Target Laboratories — ON TARGET LABORATORIES discovers and develops fluorescent markers to target and illuminate cancer during surgery so it can be removed more completely.
Equiter seleziona, realizza e gestisce investimenti infrastrutturali in capitale di rischio finalizzati allo sviluppo socio-economico del territorio.
Show more...Investment focus
- Medical, Health Care, Information Technology
- Seed, Series B, Convertible Note
- Italy
Portfolio highlights
- AWorld — AWorld is The Sustainability Platform and Mobile App chosen by the United Nations to support the ActNow Campaign.
- Medics — 3D anatomical modeling per la pianificazione pre-operatoria e il supporto intra-operatorio delle chirurgie complesse.
- Faccin Group — Faccin Group leads in manufacturing top tier metal forming & bending machines. Operating as Faccin, Roundo & Boldrini, we offer unparalleled expertise.
Principia is an Italian Venture Capital firm with over Eur 80M under management. Currently Principia has two funds investing in digital start ups and expansion capital opportunities and in particular cases, we invest also in seed opportunities.
Show more...Investment focus
- Health Care, Biotechnology, Software
- Funding Round, Series A, Seed
- Italy, United States, United Kingdom
Portfolio highlights
- KLISBio — KLISBio is a medtech company currently developing a variety of regenerative medicine implantable products leveraging the power of silk fibroin to promote an endogenous repair of human soft tissues.
- ENTEROME — We are a clinical stage biopharmaceutical company developing novel drugs to transform human health based on our unique ability to de-code molecular interactions in the gut microbiome.
- WISE — WISE (Wiringless Implantable Stretchable Electronics) is a start-up company created in 2011 with the mission of producing the new generation of leads for neuromodulation for treatment of chronic pain and Parkinson: unbreakable, less invasive and cheaper.
Kairos Partners SGR is a independent Italian asset management company.
Show more...Investment focus
- FinTech, Financial Services, Fashion
- Seed, Series A, Funding Round
- Italy
Portfolio highlights
- Viceversa — Viceversa provides capital to European digital businesses to support companies in sustainable and ethical growth. The company was founded in 2021 and has locations in Milan and Dublin.
- Hercle — Hercle is a regulated digital asset liquidity provider specializing in OTC trading and market making.
- Underscore District — Underscore District unlocks the potential of Made in Italy fashion brands through the power of technology and data analytics.
Powering Breakthroughs in Life Sciences
Show more...Investment focus
- Biotechnology, Health Care, Pharmaceutical
- Series A, Series B, Series C
- United States, Canada, United Kingdom
Portfolio highlights
- Syndax Pharmaceuticals — Syndax Pharmaceuticals is a clinical-stage pharmaceutical company that focuses on an HDAC inhibitor for solid tumors and hematological tumors. It offers therapies to treat solid tumors and lung, breast, and hematological cancer. The company is developing axatilimab, a monoclonal antibody that blocks the colony-stimulating factor 1 (CSF-1) receptor,in development for chronic Graft versus Host Disease, and entinostat, a class I HDAC inhibitor.Syndax Pharmaceuticals pipeline includes and SNDX-5613, a highly selective inhibitor of the Menin–MLL binding interaction, in development for the treatment of patients with MLLr and NPM1 acute leukemias.
- Portola Pharmaceuticals — As Alexion, AstraZeneca Rare Disease, we are delivering life-changing therapies to people living with rare diseases.
- Rhythm Pharmaceuticals — Rhythm Pharmaceuticals is a global biopharmaceutical company committed to transforming the lives of patients with rare neuroendocrine diseases by rapidly advancing care and precision medicines that address the root cause.
Riello Investimenti is a private equity investment firm. The firm prefers to invest in Italian small and medium enterprises within the manufacturing, healthcare, energy, media, and logistics sectors. It was founded in 2001 and is based in Milan, Italy.
Show more...Investment focus
- E-Commerce, Food Delivery, Food and Beverage
- Seed
- Italy
Portfolio highlights
- Soplaya — Soplaya is a B2B food company connecting chefs and farmers to build a diverse, sustainable, and efficient food system.By providing data and transparency to an opaque supply chain, we help chefs to simplify purchases, get a wider selection of products and save money and farmers to increase their margins and get easy access to the market.We lovequality food as much as technology and automation. We are rebels: we love transparency and how the internet is capable of bringing the long tail to the market. We're excited about the fact that the restaurant supply chain hasn't basically changed since 40 years, and was technology reluctant for a long time, but restaurants necessities changed dramatically in the last 3 years.We’re becoming the standard layer for restaurant purchasing across Europe, by bringing transparency and simplicity in the procurement phase, increasing order frequency, promoting lean inventory and food waste reduction.
- Bevy — Bevy is a startup that brings water, beverages and bulky products to consumers' homes.
- ExoLab Italia — Cosmetics Utilizing plant-derived exosomes in cosmetic products boosts skin absorption, enhancing bioavailability and stimulating cells to produce lacking compounds. Their ability to penetrate the dermis ensures maximum efficacy and optimal results for skincare products. more informations Supplements Plant-derived exosomes, rich in nutrients, enhance bioavailability by
Seeding change by investing in category-defining agri & foodtech ventures.
Show more...Investment focus
- Medical, Software, Health Care
- Series A, Funding Round
- Italy
Portfolio highlights
- Biorsaf — Biorsaf is an IT company that develops mobile apps and web control panels to assist companies to bring efficiency to their operations.
- Lembas — Lembas is redefining nutrition for the GLP-1 era. We craft natural, functional foods designed to work with biology - not against it. Our formulations are built for focus, recovery, and longevity, empowering a new generation of eaters to nourish smarter, not more. Explore how Lembas is re-engineering food for a world where better health begins within.
- ExoLab Italia — Cosmetics Utilizing plant-derived exosomes in cosmetic products boosts skin absorption, enhancing bioavailability and stimulating cells to produce lacking compounds. Their ability to penetrate the dermis ensures maximum efficacy and optimal results for skincare products. more informations Supplements Plant-derived exosomes, rich in nutrients, enhance bioavailability by
Ferrante Gaetani,
Show more...Investment focus
- Medical, Health Care, Medical Device
- Series A
- Italy
Portfolio highlights
- I-VASC — I-VASC has developed the VELEX device using new technology to treat CVI and varicose veins.
Sefea Impact is an asset management company that setting up and managing closed-end alternative investment funds. It aims to generate social impacts through fundamental tools such as tailored finance, technical assistance, and impact measurement.
Show more...Investment focus
- Medical, Health Care, Medical Device
- Funding Round
- Italy
Portfolio highlights
- BionIT Labs — We apply IT to Bionics in order to Turn disabilities into New Possibilities
DSM-Firmenich Venturing provides venture capital finance for startup firms.
Show more...Investment focus
- Health Care, Biotechnology, Food and Beverage
- Series A
- United States
Portfolio highlights
- one.bio — BCD Bioscience is an emerging biotechnology spinout from UC Davis that creates ingredients for food and biopharmaceutical applications. The company was founded in 2019 and is headquartered in Davis, California, United States.
- ExoLab Italia — Cosmetics Utilizing plant-derived exosomes in cosmetic products boosts skin absorption, enhancing bioavailability and stimulating cells to produce lacking compounds. Their ability to penetrate the dermis ensures maximum efficacy and optimal results for skincare products. more informations Supplements Plant-derived exosomes, rich in nutrients, enhance bioavailability by
- Enhanced Medical Nutrition — Enhanced Medical Nutrition builds clinical nutrition products to help patients prepare better and recover faster from surgery.
The GM&C Life Sciences Fund is a seed and early stage venture capital fund targeting life sciences businesses located in the Greater Manchester and Cheshire & Warrington region. The Fund is managed by Catapult Venture Managers ("Catapult Ventures").The Fund is based at Alderley Park, which is well recognised as a site ofnational importance, being the largest life sciences campus of its kind in the UK with more than 500,000 sq. ft. of top-end laboratory and related space and facilities. Until recently, the Park was the R&D headquarters for AstraZeneca.Since 2002, Catapult Ventures has backed a significant number of companies across a broad range of life sciences, including therapeutics (such as Abzena and Oxford BioTherapeutics), medical devices (such as Monica Healthcare and Probe Scientific), contract research organisations (such as R5 Pharmaceuticals and FDAS), diagnostics developers (such as Lumora and Biofortuna), as well as developers of technology used in healthcare applications (such as Oxford Cryosystems and Accutronics). The Fund is the result of a collaboration between Cheshire and Warrington Enterprise Partnership, Greater Manchester Combined Authority, Cheshire East Council, and Manchester Science Partnerships.
Show more...Investment focus
- Health Care, Biotechnology, Medical
- Seed, Funding Round, Series A
- United Kingdom, Italy, Germany
Portfolio highlights
- Gendius — Gendius was founded by Chris Genders and Rory Cameron with a view to making living with diabetes easier. The company has developed Intellin® - an App platform that uses an individual’s clinical history to predict those areas most likely of developing complications from their diabetes i.e. their individual high-risk areas. The platform then focussesthe individual on clinically validated tasks and measures to slow their progression in these areas.
- ScubaTx — ScubaTx is a breakthrough organ preservation device organ transplant. The ScubaTx device will leverage world-leading expertise in software design to commercialise a proven but unexploited organ preservation technique, Persufflation. ScubaTx will offer healthcare providers significant net savings, an
- SurgaColl — SurgaColl Technologies is a medical device company developing novel tissue regeneration products for the surgical treatment of diseases of the bone, cartilage and other human tissue. Based on technology developed at the Tissue Engineering Research Group (TERG) of the Royal College of Surgeons in Ireland (RCSI), headed by Professor Fergal O’Brien,the company aims to become a leader in the field of regenerative medical devices.
Familiy Office of Petrone Group
Show more...Investment focus
- Medical, Wellness, Health Care
- Seed
- Italy
Portfolio highlights
- BetaGlue Technologies — BetaGlue Therapeutics develops innovative targeted cancer therapy solutions using its proprietary YntraDose technology for nuclear medicine.
RoboIT is the National Technology Transfer Hub for Robotics and Industrial Automation.
Show more...Investment focus
- Medical, Manufacturing, Medical Device
- Pre-Seed
- Italy
Portfolio highlights
- SunCubes — SunCubes is an innovative startup developing wireless energy transmission technologies using lasers, enabling applications like drone recharging and remote sensor power, driving efficiency.
- Eye2Drive — EYE2DRIVE is a young company designing and building a new imaging sensor for the autonomous cars. We are based in Tuscany, Italy.
- PhotonPath — Enabling seamless integration between Photonics and Electronics for a faster, more connected and sustainable future
Rearden Capital is a trading and investment firm managing proprietary capital across commodity, currency, fixed income and equity asset classes and related derivative instruments in the global markets.
Show more...Investment focus
- Medical, Health Care, Biotechnology
- Funding Round
- Italy
Portfolio highlights
- CellPly — Cellply offers an automated platform for functional precision medicine. We provide single-cell drug response profiling to guide oncology treatments...
Toscana Next Fund is a co-investment fund managed by CDP Venture Capital.
Show more...Investment focus
- Medical, Manufacturing, Medical Device
- Pre-Seed
- Italy
Portfolio highlights
- Eye2Drive — EYE2DRIVE is a young company designing and building a new imaging sensor for the autonomous cars. We are based in Tuscany, Italy.
- Valuematic — Valuematic realizza soluzioni per il trattamento e gestione dei dati favorendo il miglioramento nei processi organizzativi e informativi di aziende ed enti.
- Next Generation Robotics — Next Generation Robotics is a company that manufactures robotic systems for inspection and monitoring for the railway industry.
Romed is an investment firm.
Show more...Investment focus
- Medical, Wellness, Health Care
- Funding Round
- Italy
Portfolio highlights
- BetaGlue Technologies — BetaGlue Therapeutics is a life sciences company that delivers radiotherapy from within. Introducing Yntradose, our proprietary product.
Giovanni Cerutti is a chief executive officer & managing director at NOVAICOS.
Show more...Investment focus
- Medical, Wellness, Health Care
- Funding Round
- Italy
Portfolio highlights
- BetaGlue Technologies — BetaGlue Therapeutics is a life sciences company that delivers radiotherapy from within. Introducing Yntradose, our proprietary product.
Rosario Bifulco, president of the auction house Finarte S.p.A.
Show more...Investment focus
- Art, Medical, Blockchain
- Seed, Pre-Seed, Series A
- Italy
Portfolio highlights
- I-VASC — I-VASC has developed the VELEX device using new technology to treat CVI and varicose veins.
- Reasoned Art — Reasoned Art is the Italian gallery dedicated to CryptoArt. it selects the best digital artists worldwide, curates physical and virtual exhibitions, and certifies the authenticity of works allowing their sale through NFT.
CRB Inverbio is a private venture capital management firm specialized in life sciences investing in innovative early stage start- ups in biotech, med tech, digital health and medical technologies
Show more...Investment focus
- Medical, Health Care, Biotechnology
- Series A, Funding Round, Seed
- Spain, Mexico
Portfolio highlights
- Nuubo — Nuubo is a Spanish medical device company that develops wireless, wearable technologies to monitor physiological parameters. To do so, Nuubo has a platform known as nECG DYNAMIC PLATFORM, which makes it easier to perform and read an electrocardiogram remotely. Specifically, the system patented by Nuubo is made up of three elements: a biomedicalgarment that allows the electrocardiogram signal to be captured without interfering with the patient’s daily activity; a device that continuously records the information captured by the garment and which also allows the data to be sent wirelessly and in real time for processing; and analysis and visualization software that, using artificial intelligence algorithms, can interpret all of the information transmitted by the wireless device.The devices designed by Nuubo allow patients’ hearts to be monitored for longer periods of time and without feeling uncomfortable or intrusive. The company is headquartered in Madrid, Spain.
- Biocross — Biocross offers diagnostic solutions that can be used during the asymptomatic phase of the diseaseand enable early detection of individuals ..
- Carol — Carol is a tech-enabled healthcare provider delivering membership-based primary care services, on a mission to make high-quality healthcare accessible and affordable for everyone. To achieve this goal, Carol leverages a highly scalable technology, combined with high quality clinical operations and a salaried provider model.
MVM invests in innovative healthcare companies. Our active portfolio companies are transforming the delivery of healthcare by enabling higher quality, cost-effective care in large, global markets.
Show more...Investment focus
- Health Care, Biotechnology, Medical
- Funding Round, Series B, Series C
- United States, United Kingdom, Switzerland
Portfolio highlights
- Ossio — OSSIO is an orthopedic fixation company committed to transforming the orthopedic experience for patients, physicians, and payors. Their vision is to provide the first credible replacement to metal implants in the $10B+ orthopedic fixation market (screws, pins, plates) with an Intelligent Bone Regeneration Technology. OSSIOfiber represents abreakthrough material platform for orthopedic and podiatric surgeons who seek a more biologically friendly way to restore patient stability and mobility with nothing permanent left behind.Founded in 2014, OSSIO began as the culmination of years of biomechanical research and a vision for the possibility of better bone healing. The technological basis of OSSIOfiber™ was developed and would lay the groundwork for ushering in a new breakthrough category of non-permanent fixation, “Bio-Integratives” hardware that has both desired strength AND bio-friendliness. Hardware that has the mechanical strength for easy insertion and secure fixation, while enabling the body to regrow bone, incorporating and replacing the implant (without the adverse inflammation and weakness often seen in “bio-resorbables and other “bio-composites”), has remained elusive to the industry until now.
- Icotec — Icotec develops and produces carbon fiber reinforced plastic implants for spine surgeries and accident treatments.
- Nalu Medical — Nalu Medical is an early-stage company that develops a range of medical devices. Their vision to modernize and improve the technology in medical devices, thus improving the lives of people.The Nalu neurostimulation system is a battery-free, micro-implantable pulse generator (iPG) currently cleared by the FDA for both Spinal Cord Stimulation (SCS)and Peripheral Nerve Stimulation (PNS) for mitigating chronic pain. The company was founded in 2014 and is based in Carlsbad, California.
Schia Ventures is investment firm.
Show more...Investment focus
- Medical, Health Care, Biotechnology
- Funding Round
- Italy
Portfolio highlights
- CellPly — Cellply offers an automated platform for functional precision medicine. We provide single-cell drug response profiling to guide oncology treatments...
Fabio Faltoni is the President of Kell.
Show more...Investment focus
- Medical, Health Care, Medical Device
- Series A
- Italy
Portfolio highlights
- I-VASC — I-VASC has developed the VELEX device using new technology to treat CVI and varicose veins.
MiMiT Women's Enterprise Fund is an investment fund.
Show more...Investment focus
- Medical, Women's, Nutrition
- Funding Round
- Italy
Portfolio highlights
- Sestre — Sestre is an online store that offers nutraceutical supplements, nutrition, Mediterranean diet, healthy, and wellness products.
CDP Equity is a holding company that has been set up to boost the Italian economy by investing venture capital in companies of "significant national interest" (as envisaged by the decrees of the Ministry of Economy and Finance of 3 May 2011 and 2 July 2014) or in companies with "economic, financial and capital balance, with adequateprospects of profitability and development, capable of generating value for investors"
Show more...Investment focus
- SaaS, Elder Care, Small and Medium Businesses
- Seed, Series A, Funding Round
- Italy, United Kingdom
Portfolio highlights
- Soplaya — Soplaya is a B2B food company connecting chefs and farmers to build a diverse, sustainable, and efficient food system.By providing data and transparency to an opaque supply chain, we help chefs to simplify purchases, get a wider selection of products and save money and farmers to increase their margins and get easy access to the market.We lovequality food as much as technology and automation. We are rebels: we love transparency and how the internet is capable of bringing the long tail to the market. We're excited about the fact that the restaurant supply chain hasn't basically changed since 40 years, and was technology reluctant for a long time, but restaurants necessities changed dramatically in the last 3 years.We’re becoming the standard layer for restaurant purchasing across Europe, by bringing transparency and simplicity in the procurement phase, increasing order frequency, promoting lean inventory and food waste reduction.
- Neuranix — Neuranix develops, manufactures, and markets innovative devices for the diagnosis of ear diseases in the medical and veterinary fields. They own several patents in the audiological field. They create products based on the analysis of the acoustic characteristics of the eardrum and middle ear measured over a broad spectrum of frequencies. Theysupport the diagnosis and monitor the therapy of middle ear pathologies.
- Rubber Conversion — Rubber Conversion provides recycling, product sustainability, custom packaging, environmental impact analysis, material tracking, and online document management. Their customers contact them through phone, email, and online applications.
Andrea Venturelli - Venture Partner @ Innogest Capital
Show more...Investment focus
- Art, Events, Retail
- Seed
- Italy, United States
Portfolio highlights
- Arcadia Earth — WHAT IS IT? Arcadia Earth is a large scale multi-sensorial journey through underwater worlds, fantasy lands, and inspirational art installations.
- CV Lab — CV Lab is the first incubator fully focused on cardiovascular innovation in Europe. It supports the most promising ideas through patenting, prototyping, and proof of concept until they mature enough to give life to a spin-off and meet international capitals. CVLab puts to good use the experience of entrepreneurs and specialists with strongexpertise in biomedical. The company collaborates with experts in the field. CVLab is a lean organization, close to researchers and clinical needs.
Antin Infrastructure Partners is a leading private equity firm focused on infrastructure investments.
Show more...Investment focus
- Energy, Renewable Energy, Beauty
- Private Equity, Funding Round, Seed
- Italy, United States, Spain
Portfolio highlights
- Power Dot — Powerdot offers electric vehicle charging solutions in convenient locations across six European countries.
- Origis Energy — Origis Energy is powering the solar revolution with solar power and energy storage projects for utility, corporate and public sector energy clients.
- Powerdot — Learn more about Powedot, a company shaping the future of sustainable mobility. Discover our mission, values, goals and much more!
UniCredit is a pan-European commercial bank offering unique banking services in Italy, Germany, Central and Eastern Europe.
Show more...Investment focus
- Energy, Manufacturing, Software
- Debt Financing, Post-IPO Debt, Seed
- Italy, Germany, Sweden
Portfolio highlights
- Noiet — Noiet is a biotechnology firm whose mission is to develop clean, natural, and fermented proteins that serve as multifunctional alternatives.
- Feralpi Group — Feralpi Group is a steel manufacturer that specializes in the production of construction steels, responsibility, safety, and innovation.
- E4 Computer Engineering — E4 Computer Engineering stands out for its tireless pursuit of the most cutting edge proposals in the IT sector.
Claris Ventures is a venture capital firm supporting the best scientists in building successful life sciences companies that will impact people's lives
Show more...Investment focus
- Biotechnology, Health Care, Therapeutics
- Seed, Series A, Series B
- Italy, United Kingdom
Portfolio highlights
- NeoPhore — NeoPhore targets the dynamics of cancer neoantigen evolution and makes effective medicines that will become a key part of the next-generation of cancer immunotherapies.
- ALKemist Bio — ALKemist Bio is a biotech startup developing next-generation T cell therapies that target ALK-positive cancers. By reprogramming the immune system, the company aims to overcome resistance and deliver more effective, lasting treatments for solid tumors.
- Iama Therapeutics — At IAMA Therapeutics, we are constantly pushing the boundaries of neuroscience drug discovery to develop new medicines and make a difference in the lives of children suffering from brain disorders and their families. Our purpose is to provide a therapeutic solution to children suffering from neurological conditions and provide their families withthe support they need.
Si14 is a visionary original design and development laboratory for novel technology products that enhance the way we live, work and play. Founded in 2008 and based in Padova, Italy, Si14 turns inspiration into the realization of compelling, cutting-edge products and services that help people connect with their activities and their world, empowerenterprises in realizing greater efficiencies, improve access to vital health screening services for millions worldwide, and much more.
Show more...Investment focus
- Medical, mHealth, Diabetes
- Seed
- Italy
Portfolio highlights
- D-EYE — D-EYE's technology enables healthcare professionals all over the world to quickly screen for problems, photograph them and then distribute them digitally via various secure wireless solutions. They design and manufacture diagnostic instruments.
Sviluppo Imprese Centro Italia is an independent asset management company founded in Florence in 1998. Active in the Private Equity and Venture Capital sector, it currently manages four closed-end funds for a total value of around 140 million euro and has already carried out numerous operations. in the capital of companies operating in variousindustrial sectors, from the most traditional to high-tech. The mission of SICI is to encourage the development of unlisted SMEs in Central Italy through the contribution of financial resources intended to strengthen their capital and financial structure. SICI intends to represent a Growth Partner for the investee companies and a strategic operator in the creation of value for the territory with an impact on the economic and social fabric in terms of competitiveness of the economic system, employment, entrepreneurial and managerial culture. Business Development Central Italy is an independent Italian managing closed-end funds company. Established in Florence in 1998, SICI has 4 Private Equity and Venture funds under management with a total committed capital of 140m Euros.
Show more...Investment focus
- Software, Travel, Medical
- Seed, Angel, Pre-Seed
- Italy
Portfolio highlights
- Cents — Cents is a platform that allows businesses to raise awareness in the market by supporting social and environmental causes.
- Parking My Car — Parking My Car offers transportation services.
- Recuperiamo srl — Recuperiamo srl is a food industry founded to prevent and reduce waste throughout the food chain. They are involved in the food industry through the Regusto brand. They can use geolocation to report on last-minute offers for their dishes.
Fondazione Golinelli was born in Bologna in 1988 by the will of the entrepreneur and philanthropist Marino Golinelli with the aim to promote education and training, to promote the culture, to foster intellectual growth and ethics of young people, the citizens of tomorrow.
Show more...Investment focus
- FinTech, Financial Services, AgTech
- Seed, Pre-Seed
- Italy
Portfolio highlights
- Biorfarm — Adotta il tuo Albero, crea il tuo Campo Digitale e ricevi a domicilio la tua frutta biologica. Solo con Biorfarm puoi seguire la crescita dei tuoi frutti!
- EvenFi — Criptalia uses blockchain technology to connect businesses that have projects to be funded with people and organizations who are looking for high-yield investments. We offer an online platform where companies publish their innovative ideas and industrial improvement projects. Investors, people, and institutions can fund these projects by lendingmoney in exchange for a higher interest rate.
- Latitudo40 — Empower sustainable growth with AI-driven satellite insights from Latitudo 40. Unlock precise, real-time data for smarter urban planning, climate risk management, and industry innovation. Enhance resilience and lead with confidence.
Green Arrow Capital is an independent financial group specializing in alternative investments across Europe. They represent a one-of-a-kind platform, capable of connecting the financial system with the real economy through the management of private equity, private debt, infrastructure, and special credit situation funds as well as thematic fundssuch as microfinance and funds of funds that are currently under management. Their team has a successful track record in asset management, investment banking, industry sectors, technology startups, management consulting, renewable energy, and has government and regulatory experience. Their group is mainly composed of investment, asset management, and financial advisory companies. Their aim is to create a solid financial platform to launch and manage investment funds dedicated to alternatives and to the real economy.
Show more...Investment focus
- Health Care, Biotechnology, Manufacturing
- Funding Round, Seed, Series A
- Italy, United Kingdom
Portfolio highlights
- Directa Plus — Directa Plus is a nanotechnology company, manufactures nanoparticles.
- Maticmind S.p.A — Maticmind S.p.A is a company that provides ICT and system integration solutions to telecommunications operators.
- Glomeria Therapeutics — Glomeria Therapeutics researches, develops, and markets new medical devices for the treatment of serious diseases in the nephrological area. It offers DesmoPD, peritoneal dialysis connection system; SmartPD, an automated management device for peritoneal dialysis solutions to be instilled in peritoneum; and solutions for peritoneal dialysis.Andrea Zanella founded Glomeria Therapeutics in 2010. Its headquarters is in Chieti in Italy.
GCM Group is an investment firm.
Show more...Investment focus
- Medical, Health Care, Biotechnology
- Seed
- Italy
Portfolio highlights
- GenomeUp — GenomeUp is an AI platform (SaaS) to enabling doctors and clinical institutions to diagnose and treat rare genetic diseases in less than 24h. GenomeUp is involved in international research projects and clinical trials in partnership with universities and research centers.
Executive Agency for SMEs
Show more...Investment focus
- Biotechnology, Software, Health Care
- Grant, Seed, Funding Round
- Spain, Switzerland, United Kingdom
Portfolio highlights
- AGADE — Esoscheletri Agade | Il primo esoscheletro intelligente per lavoratori progettato per ridurre il rischio di disturbi muscolari delle spalle nella movimentazione manuale dei carichi.
- Cyclomics — Discover Cyclomics, pioneers in precision cancer diagnostics using breakthrough consensus-sequencing paired with the Nanopore platform. Our innovative solutions enable ultra-sensitive detection of cancer mutations directly from blood samples, transforming the future of liquid biopsy. Learn more about how Cyclomics is revolutionizing early cancer detection, monitoring, and personalized treatment with cutting-edge, accessible molecular diagnostics.
- Terraplasma — As pioneers in cold plasma science, our team of scientists, engineers, and experts have played a key role in driving research and commercial development. Our groundbreaking work has brought cold plasma technology to companies, public institutions and even private households worldwide.
Fondazione Cottino is support young people in their educational path and support for scientific research, technology transfer.
Show more...Investment focus
- Medical, mHealth, Diabetes
- Seed
- Italy
Portfolio highlights
- D-EYE — D-EYE's technology enables healthcare professionals all over the world to quickly screen for problems, photograph them and then distribute them digitally via various secure wireless solutions. They design and manufacture diagnostic instruments.
Spindial Group
Show more...Investment focus
- Medical, Health Care, Biotechnology
- Funding Round
- Italy
Portfolio highlights
- Glomeria Therapeutics — Glomeria Therapeutics researches, develops, and markets new medical devices for the treatment of serious diseases in the nephrological area. It offers DesmoPD, peritoneal dialysis connection system; SmartPD, an automated management device for peritoneal dialysis solutions to be instilled in peritoneum; and solutions for peritoneal dialysis.Andrea Zanella founded Glomeria Therapeutics in 2010. Its headquarters is in Chieti in Italy.
a|impact invests in the prevailing form of equity or quasi-equity, focusing our operations mainly on companies.
Show more...Investment focus
- Medical, Health Care, Biotechnology
- Seed
- Italy
Portfolio highlights
- GenomeUp — GenomeUp is an AI platform (SaaS) to enabling doctors and clinical institutions to diagnose and treat rare genetic diseases in less than 24h. GenomeUp is involved in international research projects and clinical trials in partnership with universities and research centers.
Contact investors today
Find who invests in your industry, stage, and country in 5 minutes.
Find investors — It's Free!